Following on from my post yesterday about GSK making affordable drugs for third world countries by lifting patents on specific new medicines, it is great to see a new report showing figures that could save the EU & US $110 Billion through 2020! This will mean money back in tax payers pockets and hopefully more money pumped back into the development of new products. 

Biosimilars are the future of the Pharmaceutical world and it's a very exciting time for both well established companies and small start ups alike.